+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Novel anticancer drug discovery

Novel anticancer drug discovery

Current Opinion in Chemical Biology 3(4): 500-509

There is at present, much optimism about the possibility of finding selective anticancer drugs that will eliminate the cytotoxic side effects associated with conventional cancer chemotherapy. This hope is based on uncovering many novel molecular targets that are 'cancer-specific', which will allow the targeting of cancer cells while normal cells are spared. Thus far, encouraging results have been obtained with several of these novel agents at the preclinical level, and clinical trials have begun. These targets are involved at one level or more in tumor biology, including tumor cell proliferation, angiogenesis and metastasis. Novel targets for which advances are being made include the following: growth factor receptor tyrosine kinases such as the epidermal growth factor receptor and HER-2/neu (proliferation); the vascular endothelial growth factor receptor and the basic fibroblast growth factor receptor (angiogenesis); the oncogenic GTP-binding protein Ras (especially agents targeting Ras farnesylation, farnesyltransferase inhibitors) (proliferation); protein kinase C (proliferation and drug resistance); cyclin-dependent kinases (proliferation); and matrix metalloproteinases and angiogenin (angiogenesis and metastasis). Less explored, but potentially useful targets include the receptor tyrosine kinase platelet-derived growth factor receptor, mitogen-activated protein kinase cascade oncogenes such as Raf-1 and mitogen-activated protein kinase kinase, cell adhesion molecules such as integrins, anti-apoptosis proteins such as Bcl-2, MDM2 and survivin, and the cell life-span target telomerase.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 035407716

Download citation: RISBibTeXText

PMID: 10419854

DOI: 10.1016/s1367-5931(99)80073-8

Related references

Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues. Journal of Chemical Information and Computer Sciences 38(2): 189-199, 1998

Natural products as leads for anticancer drug discovery: discovery of new chemotypes of microtubule stabilizers through reengineering of the epothilone scaffold. Chimia 64(1-2): 8-13, 2010

Leveraging Cell Cycle Analysis in Anticancer Drug Discovery to Identify Novel Plasmodial Drug Targets. Infectious Disorders - Drug Targets 10(3): 165-190, 2010

Leveraging cell cycle analysis in anticancer drug discovery to identify novel plasmodial drug targets. Infectious Disorders Drug Targets 10(3): 165-190, 2010

Thymidylate synthase as a molecular target for drug discovery using the National Cancer Institute's Anticancer Drug Screen. Anti-Cancer Drugs 12(7): 569-574, 2001

Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1. Medical Oncology 34(10): 176, 2017

Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation. Stem Cells 29(10): 1528-1536, 2011

TGI-Simulator: a visual tool to support the preclinical phase of the drug discovery process by assessing in silico the effect of an anticancer drug. Computer Methods and Programs in Biomedicine 105(2): 162-174, 2012

Molecular characterization of the NCI human tumor cell line anticancer drug screen and database mining for drug re-discovery and hypothetical pharmacology. Proceedings of the American Association for Cancer Research Annual Meeting 40: 407, 1999

Anticancer drug discovery. Journal of the National Cancer Institute 83(11): 738-740, 1991

Suramin the discovery of an old anticancer drug. Medical Oncology and Tumor Pharmacotherapy 7(4): 287-290, 1990

Serendipity in anticancer drug discovery. World Journal of Clinical Oncology 3(1): 1-6, 2012

Anticancer drug discovery and development. Advances in Experimental Medicine and Biology 610: 19-42, 2008

Anticancer Drug Discovery from the Marine Environment. Recent Patents on Anti-Cancer Drug Discovery 7(2): 218-232, 2012

Anticancer drug discovery and development throughout the world. Journal of Clinical Oncology 20(18 Suppl): 47s, 2002